tradingkey.logo

Heartbeam Inc

BEAT
View Detailed Chart
1.650USD
0.000
Close 11/05, 16:00ETQuotes delayed by 15 min
56.13MMarket Cap
LossP/E TTM

Heartbeam Inc

1.650
0.000
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

+3.13%

1 Month

-15.38%

6 Months

-10.33%

Year to Date

-28.26%

1 Year

-32.38%

View Detailed Chart

TradingKey Stock Score of Heartbeam Inc

Currency: USD Updated: 2025-10-27

Key Insights

Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Heartbeam Inc's Score

Industry at a Glance

Industry Ranking
159 / 204
Overall Ranking
468 / 4682
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 3 analysts
Buy
Current Rating
4.333
Target Price
+162.63%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Heartbeam Inc Highlights

StrengthsRisks
HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 0.00.
Fairly Valued
The company’s latest PE is -2.32, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 3.60M shares, increasing 9.65% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.12M shares of this stock.

Heartbeam Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Heartbeam Inc Info

HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.
Ticker SymbolBEAT
CompanyHeartbeam Inc
CEOMr. Robert P. (Rob) Eno
Websitehttps://www.heartbeam.com/
KeyAI